Literature DB >> 17001647

Docking of human interleukin-15 to its specific receptor alpha chain: correlation between molecular modeling and mutagenesis experimental data.

Agnès Quéméner1, Jérôme Bernard, Erwan Mortier, Ariane Plet, Yannick Jacques, Vinh Tran.   

Abstract

A structural model of the sushi domain of IL-15Ralpha was first obtained by homology modeling to study its interactions with IL-15 by means of molecular modeling, peptide scanning, and site-directed mutagenesis. From these experimental data, a putative interacting surface of IL-15Ralpha with a previously published IL-15 model was inferred: Leu25, Leu44, and Glu46 of IL-15 and Arg35 of IL-15Ralpha were found to be key interfacial residues and were subsequently used as filters for the construction of docking solutions. Human IL-15/IL-15Ralpha complexes were constructed in two stages, with a preliminary docking procedure, treating the two partners as rigid bodies and using these filters. In this first stage, two classes of docking solutions were characterized. From a topological point of view, each solution could be derived from the other by reverse orientation of one partner in relation to the other. In a second stage, several further energy refinements clearly favored one solution. Moreover, this unique docking solution was confirmed by molecular modeling of IL-15 mutants previously built and tested in our laboratory. Finally, this complex model, which is a useful tool to study the IL-15/IL-15Ralpha interface, was topologically compared to IL-2/IL-2Ralpha complexes (previous model in the literature and recent crystal structure). (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17001647     DOI: 10.1002/prot.21103

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  4 in total

1.  Design of potent inhibitors of human RAD51 recombinase based on BRC motifs of BRCA2 protein: modeling and experimental validation of a chimera peptide.

Authors:  Julian Nomme; Axelle Renodon-Cornière; Yuya Asanomi; Kazuyasu Sakaguchi; Alicja Z Stasiak; Andrzej Stasiak; Bengt Norden; Vinh Tran; Masayuki Takahashi
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

2.  Novel human interleukin-15 agonists.

Authors:  Xiaoyun Zhu; Warren D Marcus; Wenxin Xu; Hyung-il Lee; Kaiping Han; Jack O Egan; Jason L Yovandich; Peter R Rhode; Hing C Wong
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

Review 3.  Memory T cells: strategies for optimizing tumor immunotherapy.

Authors:  Qingjun Liu; Zhongjie Sun; Ligong Chen
Journal:  Protein Cell       Date:  2020-03-27       Impact factor: 14.870

4.  Mechanistic and Structural Insights on the IL-15 System through Molecular Dynamics Simulations.

Authors:  Rui P Sousa; Adèle D Laurent; Agnès Quéméner; Erwan Mortier; Jean-Yves Le Questel
Journal:  Molecules       Date:  2019-09-06       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.